Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(9 sites)
United Kingdom
The Christie NHS Foundation Trust, Manchester, Greater Manchester Addenbrooke's Hospital Cambridge University Hospitals NHS Foundation Trust, Cambridge Beatson West of Scotland Cancer Centre, Glasgow Hope Clinical Trials Cancer Centre, Leicester Barts Cancer Institute, London Royal Marsden NHS Foundation Trust, London University College London Hospitals NHS Foundation Trust, London Nottingham University Hospital, Nottingham Weston Park Hospital, Sheffield